Methods that monitor the quality of a biological assay (i.e., its ability to discriminate between positive and negative controls) are essential for the development of robust assays. In screening, the most commonly used parameter for monitoring assay quality is the Z' factor, which is based on 1 selected readout. However, biological assays are able to monitor multiple readouts. For example, novel multiparametric screening technologies such as high-content screening provide information-rich data sets with multiple readouts on a compound's effect. Still, assay quality is commonly assessed by the Z' factor based on a single selected readout. This report suggests an extension of the Z' factor, which integrates multiple readouts for assay quality assessment. Using linear projections, multiple readouts are condensed to a single parameter, based on which the assay quality is monitored. The authors illustrate and evaluate this approach using simulated data and real-world data from a highcontent screen. The suggested approach is applicable during assay development, to optimize the image analysis, as well as during screening to monitor assay robustness. Furthermore, data sets from high-content imaging assays and other state-of-the-art multiparametric screening technologies, such as flow cytometry or transcript analysis, could be analyzed. (Journal of Biomolecular Screening 2010:95-101) Key words: Z' factor, assay quality, high-content screening, multiparametric data analysis Kümmel et al. 96 www.sbsonline.org Journal of Biomolecular Screening 15(1); 2010
INTRODUCTION
T he Z' factor is the most commonly used parameter to monitor the quality of an assay and to track assay performance during a screening campaign. 1 Although there are a number of different statistics to measure assay quality, 2-4 the advantage of the Z' factor is its simplicity and intuitive clarity, reducing the amplitude and variability of the assay signal to only 1 parameter. 1 The value of having such a statistic is that it can be used during assay development to assess the effect of changing assay conditions on the suitability of the assay for high-throughput screening (HTS). In addition, the Z' factor is regularly used to monitor the performance of an assay during a screening campaign as a quality control measure for each screening plate. The application of the Z' factor has been extended by using robust statistics, lowering the influence of outliers on the calculated Z' factor. 5 High-content screening (HCS) can provide information-rich data sets containing readouts on multiple cellular parameters, such as the number of cells, their shape, and even the intracellular distribution of cellular proteins. The image-based HCS has facilitated the discovery of a number of small molecules or siRNA reagents with interesting biological functions (e.g., Giuliano et al. 6 and Wilson et al. 7 ). To monitor the sustained quality of screening assays, a "classical" Z' factor as used in assays with only a single readout is usually calculated using a preselected image readout (e.g., the intensity of a certain fluorescent stain). 7 To address specific statistical properties of image readouts, the V factor has been suggested as an alternative method to monitor assay performance of HCS assays and the effect of different image acquisition and analysis settings (see Ravkin, 8 available at http://www.ravkin.net/posters/index .htm). Yet, this method analyzes each image readout separately. The presence of multiple readouts, however, provides the possibility of improving the discrimination of positive and negative controls, as well as the identification and prioritization of active compounds using a multivariate analysis. 9 At present, there is no accepted method to monitor assay quality based on multiple readouts simultaneously. Such a method would enable the assessment of the image readouts' suitability to monitor relevant biological effects. Furthermore, the implications of adjusting image analysis settings or variations in the following data manipulation steps, such as dimension reduction, could be quantified and compared.
Here, we illustrate the shortcomings of a univariate approach in comparison to a truly multivariate quality assessment of an HCS assay. For the multivariate analysis, we propose a multivariate Z' factor as a means to monitor assay quality in HCS data sets. Exemplarily, a data set generated in an HCS cell cycle assay was analyzed with respect to its ability to discriminate between normally proliferating cells and cells that were treated with nocodazole, which arrests cells in mitosis. The proposed assay statistic could also be applied to assess the quality of other assay formats, which generate multiple readouts, such as transcript analysis or fluorescence-activated cell sorting (FACS).
MATERIALS AND METHODS
To evaluate the multivariate Z' factor calculation proposed here, we used the results from an HCS assay monitoring cell proliferation modulated by small molecules. 10 In this screen, 3 fluorescent dyes (channel 1 [Ch1]: DNA staining with Hoechst; channel 2 [Ch2]: antibody staining of phosphorylated histone 3 [pH 3] to detect mitotic cells; channel 3 [Ch3]: monitoring incorporation of EdU as an indicator of DNA replication in S-phase) were used to monitor the cell cycle phase of a given cell. Images of the cells were taken by automated fluorescence microscopy. Image analysis was conducted using Cellomics BioApplication software (Morphology Analysis.V3, Version 6.0) to provide 33 readouts describing the cellular phenotype (see supplementary file S3 at http://jbx.sagepub.com/supp lemental). After data preprocessing (see supplementary file S3 at http://jbx.sagepub.com/supplemental), each sample (i.e., each well in a 384-format plate) was described with the median value of the cell population for each image readout. We aimed to assess how well treatments with either DMSO (the negative control) or nocodazole (the positive control)-which is known to arrest cells in mitosis-can be discriminated by drawing on these 33 image readouts. To have a sufficient number of samples for evaluating the proposed method, we pooled 175 DMSO and 72 nocodazole samples from 20 screening plates.
RESULTS AND DISCUSSION

Univariate versus bivariate Z' factor analysis
Assay quality (i.e., whether positive and negative controls can be discriminated from each other) is commonly assessed using the Z' factor of a single assay readout. Following this approach, the Z' factors for all 33 image parameters and their natural logarithms were calculated. Logarithmic data transformation can be used to yield a more Gaussian distribution of parameter values, which can alter the Z' factor. 4 The highest (univariate) Z' factor was 0.25 for "SkewIntenCh1," a readout on the intensity distribution of the nuclear Hoechst staining. The second best Z' factor, 0.15, was calculated for the natural logarithm of the total intensity of the EdU staining, "lnTotalIn-tenCh2" (Fig. 1) . A Z' factor >0.5 indicates an assay suitable for HTS. Obviously, analyzing each parameter separately did not provide satisfactory separation of the control samples.
A scatter plot of the 2 image readouts with the best "classical" Z' factors ( Fig. 1) illustrates that the DMSO and nocodazole samples are indeed distinct from each other. Therefore, we assessed whether the discrimination between the control samples could be improved by combining the information of both parameters. For example, the 2 parameters can be condensed into a single value by a weighted sum, which can be thought of as projecting these values onto a single line. The black line in Figure 1 indicates a weighted sum of the 2 best discriminating parameters (i.e., (+1) . lnTotalIntenCh2 + (-1) . SkewIntenCh1). The Z' factor calculated for data points projected onto this line was 0.44. Hence, by combining the information from both parameters, the controls are better discriminated. This example was limited to 2 dimensions for illustration purposes, but even more parameters can be incorporated into the Z' factor calculation, which presumably enhances the discrimination between the 2 control groups further.
Translation of the Z' factor to multiple dimensions by linear projection
To fully exploit the information available in a multivariate data set when calculating the Z' factor, we used the idea outlined above to linearly project data points from multidimensional space onto a line. The values derived from these projections were then used to calculate a multivariate Z' factor. The steps to calculate the projected data points and the Z' factor are expressed in equations (1) to (6) . The projected value of a data point, P i , was calculated by a weighted sum of the original data values, x ij , for all parameters j (with D as the number of assay parameters). Analog to the original calculation, the Z' factor was determined based on the means and standard deviations of the projected values, P, for each group (positive and negative). 
Now, the projection weights, w j , had to be determined such that a suitable Z' factor was obtained from the values P. An evaluation of different methods to determine projection weights using simulated data and the cell cycle data set can be found in supplementary files S0 to S3 (http://jbx.sagepub.com/supplemental; see Bishop 11 for a general introduction to multivariate classification methods). The method of choice was linear discriminant analysis (LDA) as it turned out to robustly yield the highest possible Z' factors and is a widely used method.
Application to cell cycle data set
The ability to discriminate between DMSO and nocodazoletreated samples in the cell cycle data set was assessed with the Z' factor based on an LDA projection. The multivariate Z' factor was much higher than the best univariate Z' factor (i.e., 0.25 for "SkewIntenCh1"; Table 1 ), demonstrating the superiority of a multivariate analysis to discriminate between controls.
Large absolute projection weights did not directly translate into a ranking of the parameters' independent control discrimination ability. For example, the projection weights for the image parameters "EqCircDiamCh1" and "EqSphereAreaCh1," both morphological readouts of the Hoechst staining, contributed most to the direction to discriminate between the controls. However, these parameters did not have good univariate Z' factors (-0.19 for both). In contrast, the parameters that in a univariate manner best discriminated between the controls ("SkewIntenCh1" and "TotalIntenCh2") had low absolute weights. As also noticed with the simulated data (supplementary files S1 and S2 at http://jbx.sagepub.com/supplemental), correlated parameters (e.g., "EqCircDiamCh1" and "EqSphereAreaCh1") can contribute to the separation of the controls when considered together much more than when taken separately.
To estimate the error of the Z' factors and the projection weights, we applied bootstrapping. Bootstrapping is a method used in statistical sciences where data points from the real data set are randomly resampled with replacement to simulate data sets of equal size as the original data set. This method allows for estimating the error of the calculation results when replicate data sets are not available.
Although the Z' factors were very similar for all bootstrapped data sets, the projection weights were highly variable for some readouts (see Fig. 2A ). For example, the image readouts "EqCircDiamCh1" and "EqSphereAreaCh1" (no. 10 and 14), which are nuclear shape parameters, often had high weights.
For some bootstrap data sets, they had rather low weights. In these cases, the image readouts "ConvexHullAreaRatioCh1" and/or "ConvexHullPerimRatioCh1" (no. 4 and 5), which also describe the shape of the nucleus, had high weights instead (see supplementary file S3 at http://jbx.sagepub.com/supplemental). Such parameter correlation-or redundancy-leads to a somewhat arbitrary weight assignment and thus high variability.
Effects of dimension reduction with factor analysis
Feng et al. 12 applied factor analysis to reduce the dimension of the data set. They showed that this dimension reduction technique combines correlated image readouts such that the new parameters can be interpreted biologically (see supplementary file S3 at http://jbx.sagepub.com/supplemental). For example, image readouts that describe the nuclear size are integrated into one factor. We employed the multivariate Z' factor to exemplarily evaluate the effects of this data manipulation. The number of parameters was reduced to 7 factors describing each cell, and again, the Z' factor was calculated based on an LDA projection.
The Z' factor was lower for the factor-reduced data set compared to the original one immediately showing that the discrimination ability was reduced by the dimension reduction. As the dimension reduction based on factor analysis led to less redundant parameters, higher robustness of the projection weights was achieved (see Fig. 2) .
Again, the projection weights show that parameters that independently do not discriminate between the controls can gain value in a multivariate analysis. Factor 2, which measures nuclear convexity, might not be selected as an assay readout to be monitored because it hardly discriminated between the controls. It is, however, helpful for discrimination if factor 1, to which it is correlated within the control groups, is also measured (see supplementary file S3 at http://jbx.sagepub.com/ supplemental). Using only factor 1, which measures nuclear size, 2.5% of the controls were wrongly classified in a 10-fold cross-validation of a linear discriminant classifier (see supplementary file S3 at http://jbx.sagepub.com/supplemental). Only 0.4% of the samples were misclassified when simultaneously considering factors 1 and 2. Relying on the factors with the highest weights (1, 2, and 7) simultaneously for discrimination, no sample was classified wrongly. Vice versa, if only factors 3 to 6 were considered, the false prediction rate was 1.2%. The projection weights thus measure the importance of each readout for multivariate discrimination between the controls (see Fig. 3) .
Moreover, the projection weights calculated for the factorreduced data set pinpointed to the known effect of nocodazole. The LDA identified factor 7, which measures the amount of pH3, as the parameter with the highest projection weight. As mentioned previously, nocodazole arrests cells in mitosis, and more of the cells exhibit this staining after nocodazole treatment because histone 3 is selectively phosphorylated during mitosis. 
Application comments
This report describes a simple and easy to implement method to calculate a Z' factor based on multiple assay readouts, which was demonstrated in a published cell cycle data set. In supplementary file S5 (http://jbx.sagepub.com/supplemental), we give another example of an HCS data set that illustrates the application of the multivariate Z' factor for assay development by comparing different incubation times and DMSO concentrations.
The method projects the multiple assay readouts onto a straight line, allowing direct application of the commonly used Z' factor to such multivariate assays. This multivariate Z' factor reports on the ability to discriminate between controls for assays with multiple readouts. Simultaneous consideration of multiple parameters compared to independent analysis of the readouts improved the discrimination ability between controls, as indicated by higher Z' values. Such a quality control parameter can be used to optimize the discrimination between control groups when changing experimental, image analysis, or data analysis settings.
The projection weights reflect the importance of these parameters for discrimination between controls. This was demonstrated by the respective classification accuracies using different sets of factors to discriminate between nocodazole and DMSO. During assay development, such an analysis can assist in selecting important readouts to be monitored. As our approach is data driven and unbiased, even readouts that are unexpected, from a biological point of view, are not discarded a priori, and valuable information is kept.
In the case of highly correlated and thus redundant parameters, a high projection weight is assigned to only one of them, as demonstrated with the nuclear shape parameters of the cell cycle data set. A high weight for another descriptor, among highly correlated parameters, could have resulted in a similar Z' value. Thus, interpreting the weights is difficult as they are to some extent arbitrary. In our analysis, dimension reduction reduced such issues of weight variability and interpretation. However, dimension reduction inherently leads to a loss of information, which was here quantified by the lower multivariate Z' factor. Other dimension reduction methods could be applied alternatively, which may not lead to an inadmissible lower Z' factor. The resulting Z' factors could assist in choosing the appropriate approach.
Obtaining good estimates of the population distribution in higher dimensions requires a larger number of control samples. The robustness of the projection weights and resulting Z' factors with varying sample numbers was analyzed (see supplementary file S2 at http://jbx.sagepub.com/supplemental). At low numbers of samples, the resulting Z' factor varied only to a limited extent compared to the projection weights. The number of samples needed to reliably determine the Z' factor and the projection weights depends on the number of parameters and their (co)variances in each case. Therefore, the sufficient number of samples cannot be stated in general but has to be estimated for each assay. During screening, there may not be enough control samples on each plate to yield reliable projection weights. Nevertheless, the contribution of the parameters to the discrimination can be explored during assay development using larger sample sizes. These predetermined projection weights can be reapplied to each screening plate, such that the variability from plate to plate can be monitored based on the multivariate Z' factor. Interestingly, a superior performance of the unsupervised principal component analysis (PCA) above supervised LDA for dimension reduction for small sample numbers was shown. 13 Hence, for some cases for which the number of available samples is rather small, other methods, including unsupervised methods such as PCA, might become superior to LDA.
Different methods to calculate a linear projection of the multi parametric descriptions were tested based on a comparative evaluation of these methods using simulated as well as real HCS data. LDA proved to be useful in extracting information from the multiple assay parameters as it allows for a good discrimination between controls (i.e., high Z' factors). In addition, LDA resulted in limited variability for the calculated Z' factor and projection weights. LDA is implemented in software packages, such as R, SAS, or Matlab. This method was also implemented in an easy-to-use Excel spreadsheet, provided as supplementary file S4 (http://jbx.sagepub.com/supplemental). We do not insist on this method because for a particular application, other methods might be better suited.
Possible extensions to the approach suggested here include using robust statistical methods such as the median instead of mean or using median absolute deviation (MAD) instead of the standard deviation. Furthermore, the calculations are not limited to the Z' factor but can also be used to calculate a Z' factor. The latter one assesses the dissimilarity of the positive control population to the population of all tested compounds, which to a large extent are not affecting the assay and thus are similar to negative controls. As users gain experience in using linear projections to calculate Z' factors for multiparametric assays, the best methods will become clear, as well as which values for such Z' factors indicate an acceptable assay.
One point to stress is that using such a tool-as for the "classical" Z' factor-is only possible if control samples are available. Thus, one pitfall is that the assay will be optimized for identification of conditions causing similar phenotypes to that control. This might limit the assay's ability to identify novel phenotypes, one of the advantages of HCS. It is important to note that the Z' factor's application for hit identification has not been evaluated here. However, if a multivariate analysis is used to decide on the assay's suitability for screening, an according multivariate approach has to be applied for hit identification. A compelling example that automated multivariate hit selection is superior to a univariate one was demonstrated by Dürr et al. 9 using a SVM with Gaussian kernel. The affinity, which is a generalization of the distance to the separating hyperplane for nonlinear projections, could be used as a projection value for Z' factor calculation in this case. In the present work, the methods were restricted to linear methods that enable an easy interpretation of the projection weights. In any case, it is recommended to examine the projection weights to investigate which effects will dominate the potential hit selection.
For an unbiased hit selection, other data-mining approaches that do not rely on predefined sample classes as positive controls should be used to fully exploit the multidimensional response/parameter space. In these cases, the LDA projection can still be used in assay development for studying assay robustness and for exploring the effect of positive controls via the projection weights. The Z' factor obviously only reflects (1) whether the selected tool compounds can be discriminated from untreated samples and (2) based on which effect(s) they are discriminated. It is inherently impossible to assess whether an assay is able to detect effects that are unevoked by the used control compounds.
Another point to consider is the effect of different control compound concentrations on the projection. For example, a sample treated with a lower concentration of the positive control may not necessarily lie in the space exactly between the negative and positive controls with the original concentration. If such samples are used as positive controls instead, the projection weights will differ. These changes of the projection weights would indicate that the assay readouts do not have the same dynamic response during a concentration response titration. For the HCS data set analyzed here, samples with intermediate concentrations of nocodazole are projected to intermediate values between DMSO and nocodazole (data not shown).
This report describes the projection of multiple readouts to calculate a Z' factor for HCS data. There is no per se restriction to also apply this approach to other cases in which 2 groups are described with more readouts and the discrimination between the groups has to be assessed. Hence, this method can potentially show usefulness for other technologies that generate multivariate descriptions of a sample, such as FACS or fluorometric imaging plate reader (FLIPR) assays (see supplementary file S5 at http://jbx.sagepub.com/supplemental). The multivariate Z' factor could also be applied to explore the benefit of multiplexing different, univariate assays to improve the discrimination power when using all available results. The scope of this analysis could also be expanded beyond the discrimination between wells and treatments. For example, this concept could be applied to single-cell data for assessing the ability to distinguish between subpopulations within a well.
